Dr. Luongo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Box 7105
Boston, MA 02111Phone+1 617-636-6317
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2004 - 2006
University of British ColumbiaClass of 1999
Certifications & Licensure
MA State Medical License 2008 - 2025
FL State Medical License 2006 - 2015
TX State Medical License 2005 - 2006- American Board of Urology Urology
- Society of Urologic OncologyUrologic Oncology Fellow
Awards, Honors, & Recognition
- Boston Magazine Top Doctors Castle Connolly, 2018-2021
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Publications & Presentations
PubMed
- 31 citationsProstatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy.Rajinikanth Ayyathurai, Pablo Gomez, Tony Luongo, Mark S. Soloway, Murugesan Manoharan
BJU International. 2007-11-01 - 28 citationsAn evidence review of active surveillance in men with localized prostate cancer.Stanley Ip, Issa J Dahabreh, Mei Chung, Winifred W Yu, Ethan M Balk
Evidence Report/technology Assessment. 2011-12-01 - 29 citationsSchedule dependent efficacy of gefitinib and docetaxel for bladder cancer.Wassim Kassouf, Tony Luongo, Gordon A. Brown, Liana Adam, Colin P.N. Dinney
The Journal of Urology. 2006-08-01
Press Mentions
What You Need to Know About Prostate CancerMay 20th, 2022- Novel Drug for Treatment of Upper Tract Urothelial CancerOctober 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
